We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

17 hedge funds and large institutions have $1.59M invested in Bio-Path Holdings Inc in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $1.51M → $1.59M (+$86K)

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$60.8K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$43.8K
3
Morgan Stanley
Morgan Stanley
New York
+$30.6K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$18.4K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.88K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$56.6K
2
VF
Virtu Financial
New York
-$38K
3
UBS Group
UBS Group
Switzerland
-$3.31K
4
Northern Trust
Northern Trust
Illinois
-$1.42K
5
MCC
Money Concepts Capital
Florida
-$1K

BPTH Hedge Fund Activity: Q2 2022 in Review

17 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2022, worth a combined $1.59M — up 5.7% from $1.51M a quarter earlier.

Fund positioning in BPTH was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $60.8K. The largest seller was BlackRock, cutting an estimated $56.6K.

  • 17 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $1.59M of Bio-Path Holdings Inc stock for Q2 2022, up 5.7% quarter-over-quarter.
  • 2 funds opened new Bio-Path Holdings Inc positions in Q2 2022 and 2 closed out, a net change of 0 holders.
  • The largest Bio-Path Holdings Inc buyer in Q2 2022 was Renaissance Technologies, an estimated $60.8K added.
  • The largest Bio-Path Holdings Inc seller in Q2 2022 was BlackRock, an estimated $56.6K sold.

Based on aggregated 13F filings for Q2 2022.